Wegovy (semaglutide) is really a prescription medication primarily useful for weight reduction in adults. It is indicated for chronic weight reduction in individuals who have obesity or are overweight and have a minumum of one weight-related medical condition. Here are the principal uses of Wegovy: Obesity Treatment: Wegovy is specifically approved for folks with a body mass index (BMI) of 30 or greater. Additionally it is approved for individuals with a BMI of 27 or greater who have a minumum of one weight-related medical condition such as type 2 diabetes, raised blood pressure, or high cholesterol. Weight Loss: Wegovy is prescribed to assist in weight reduction by influencing appetite control and regulating blood sugar levels. The medication was created to be used together with a reduced-calorie diet and increased exercise for comprehensive weight reduction. Appetite Control: Semaglutide, the active component in Wegovy, is a GLP-1 receptor agonist that mimics the consequences of the natural hormone GLP-1. By activating GLP-1 receptors in the mind, Wegovy helps reduce hunger and increase feelings of fullness, adding to a decreased caloric intake. Improvement in Metabolic Health: Beyond weight loss, Wegovy has demonstrated positive effects on metabolic health, including improved blood sugar control. This is often particularly beneficial for individuals with type 2 diabetes or other metabolic conditions. Chronic Weight Management: Wegovy is supposed for long-term use to support chronic weight reduction efforts. It isn't a short-term solution but is part of a comprehensive approach which includes lifestyle modifications, like a nutritious diet and increased physical activity. It's important to note that Wegovy is a prescription drugs, and its use ought to be guided by a doctor. Before starting Wegovy, individuals should consult with their doctor to assess eligibility, discuss potential benefits and risks, and ensure that it aligns making use of their general health goals. Additionally, healthcare professionals may monitor individuals using Wegovy to track progress and address any potential unwanted effects.
GLP-1 receptor agonist
